Exciting Advances in Ulcerative Colitis Treatments: Skyrizi Gains Early Momentum Following FDA Approval in June
Long-Term Psoriatic Arthritis Data for AbbVie’s Skyrizi Likely to Impact Future IL-23 Preference, Spherix Global Insights Reports
The Oral GLP-1 Tracker: Novo’s oral Wegovy hits 3M prescription milestone as Lilly’s Foundayo chugs along in early launch
Spherix Global Insights Launches RapidPulse Dynamix™ to Support Time-Sensitive Market Insights
